Ginwa Enterprise (Group) Inc.

600080

CNE000000QQ8

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 04/07/2024 am IST			5-day change	1st Jan Change
5.84 ^CNY	-2.83%		-2.99%	-21.61%

22/05	Ginwa Enterprise Inc.'s Equity Buyback announced on February 21, 2024, has closed with 20,557,582 shares, representing 5.56% for CNY 149.49 million.	CI
22/05	Tranche Update on Ginwa Enterprise Inc.'s Equity Buyback Plan announced on February 21, 2024.	CI

Tranche Update on Ginwa Enterprise Inc.'s Equity Buyback Plan announced on February 21, 2024.

May 22, 2024

From April 1, 2024 to May 22, 2024, the company has repurchased 4,207,900 shares, representing 1.18% for CNY 29.28 million. With this, the company has completed the repurchase of 20,557,582 shares, representing 5.56% for CNY 149.49 million under the buyback announced on February 21, 2024.

Latest news about Ginwa Enterprise (Group) Inc.

Ginwa Enterprise Inc.'s Equity Buyback announced on February 21, 2024, has closed with 20,557,582 shares, representing 5.56% for CNY 149.49 million.	22/05	CI
Tranche Update on Ginwa Enterprise Inc.'s Equity Buyback Plan announced on February 21, 2024.	22/05	CI
Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
Ginwa Enterprise Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/04	CI
Tranche Update on Ginwa Enterprise Inc.'s Equity Buyback Plan announced on February 21, 2024.	03/04	CI
Ginwa Enterprise Inc. announces an Equity Buyback for CNY 150 million worth of its shares.	21/02	CI
Ginwa Enterprise Inc. authorizes a Buyback Plan.	20/02	CI
Western Investment Group Co., Ltd. completed the acquisition of Ginwa International Hotel Co., Ltd. from Ginwa Enterprise Inc..	02/02	CI
Ginwa Enterprise Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
Shaanxi Xiangfeng Industrial Development Co., Ltd. completed the acquisition of 8.39% stake in Chongqing Pharmaceutical Group Shaanxi Co. , Ltd. from Ginwa Enterprise Inc..	18/23/18	CI
Shaanxi Xiangfeng Industrial Development Co., Ltd. agreed to acquire 8.39% stake in Chongqing Pharmaceutical Group Shaanxi Co. , Ltd. from Ginwa Enterprise Inc. for CNY 14.18 million.	09/23/09	CI
Ginwa Enterprise Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	18/23/18	CI
Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Xinyu Jinyu Enterprise Management Co., Ltd. completed the acquisition of 5.04% stake in Ginwa Enterprise Inc. from Xinyu Xingpeng Tongchuang Enterprise Management Partnership (Limited Partnership).	01/23/01	CI
Ginwa Enterprise to Apply For 400 Million Yuan Bank Loan	16/23/16	MT
Xinyu Jinyu Enterprise Management Co., Ltd. signed share transfer contract to acquire 5.04% stake in Ginwa Enterprise Inc. from Xinyu Xingpeng Tongchuang Enterprise Management Partnership (Limited Partnership) for CNY 150 million.	22/22/22	CI
Western Investment Group Co., Ltd. entered into an Equity Transfer Agreement to acquire Ginwa International Hotel Co., Ltd. from Ginwa Enterprise Inc. for CNY 344.5 million.	17/22/17	CI
Ginwa Enterprise Drops Planned 111 Million Yuan Property Purchase	05/22/05	MT
Xiangyunhe Juli No. 6 Private Securities Investment Fund, managed by Nanjing Xiangyunhe Investment Management Co., Ltd cancelled the acquisition of a 3.03% stake in Ginwa Enterprise Inc. (SHSE : 600080) from Century Ginwa Co., Ltd.	11/22/11	CI
Ginwa Enterprise Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
Xiangyunhe Juli No. 6 Private Securities Investment Fund, managed by Nanjing Xiangyunhe Investment Management Co., Ltd agreed to acquire a 3.03% stake in Ginwa Enterprise Inc. from Century Ginwa Co., Ltd. for CNY 96.1 million.	01/22/01	CI
Jinbozhu Heju No. 4 Private Securities Investment Fund managed by Nanjing Jinbozhu Asset Management Co., Ltd. agreed to acquire a 5.01% stake in Ginwa Enterprise Inc. from Century Ginwa Co., Ltd. for approximately CNY 160 million.	01/22/01	CI
Ginwa Enterprise Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	19/22/19	CI
Century Ginwa Retail Shareholders to Vote July 7 on Sale of Entire 8% Stake in Ginwa Enterprise	26/22/26	MT
Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	21/22/21	CI

Chart Ginwa Enterprise (Group) Inc.

Duration

Period

More charts

Company Profile

Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.

Sector

Pharmaceuticals

Calendar

19/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GINWA ENTERPRISE (GROUP) INC.	-21.61%	29Cr
ELI LILLY AND COMPANY	+55.82%	81TCr
NOVO NORDISK A/S	+39.44%	62TCr
JOHNSON & JOHNSON	-7.52%	35TCr
ABBVIE INC.	+6.26%	29TCr
ASTRAZENECA PLC	+13.15%	24TCr
NOVARTIS AG	+13.84%	22TCr
ROCHE HOLDING AG	-0.45%	22TCr
AMGEN INC.	+7.63%	17TCr
PFIZER, INC.	-3.20%	16TCr